Director Thomas C. Besselman resigns from Investar Holding board, withdraws as nominee

Investar Holding Corp

Director Thomas C. Besselman resigned effective April 18, 2022, withdrew as nominee for May 18 annual meeting.
Resignation not due to any disagreement with company on operations, policies or practices.
Board accepted resignation, reducing size from 12 to 11 on April 20, 2022.
Other proxy nominees unchanged; proxy card remains valid.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Thomas C. Besselman, Sr.

Director

ISTR · Investar Holding Corp

Effective: 2022-04-18
Filed: April 21, 2022, 7:59 PM ET

On April 18, 2022, Thomas C. Besselman, Sr. notified Investar Holding Corporation (the “Company”) of his resignation from the Board of Directors (the “Board”) of the Company, effective immediately, and his withdrawal as a director nominee for election at the 2022 Annual Meeting of Shareholders of the Company (the “2022 Annual Meeting”) on May 18, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Thomas C. Besselman, Sr. resigned as Director at Investar Holding Corp.

Action: resigned
Role: Director

Exact text from the filing

On April 18, 2022, Thomas C. Besselman, Sr. notified Investar Holding Corporation (the “Company”) of his resignation from the Board of Directors (the “Board”) of the Company, effective immediately, and his withdrawal as a director nominee for election at the 2022 Annual Meeting of Shareholders of the Company (the “2022 Annual Meeting”) on May 18, 2022.

View on SEC.gov

Investar Holding Corp filing history →

Source: SEC EDGAR

accession 0001437749-22-009439

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.